PedAM
Pediatric Disease Annotations & Medicines
| Disease | hematopoietic stem cell transplantation |
| Phenotype | C0026764|multiple myeloma |
| Sentences | 22 |
| PubMedID- 26190662 | Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy. |
| PubMedID- 26550130 | The efficacy and safety of single-agent bortezomib or bortezomib-based regimens as consolidation therapy after autologous hematopoietic stem cell transplantation (asct) in patients with multiple myeloma (mm) has been in question. |
| PubMedID- 26325439 | Cd34-selected allogeneic hematopoietic stem cell transplantation for patients with relapsed, high-risk multiple myeloma. |
| PubMedID- 24137301 | Therapeutic effects of autologous hematopoietic stem cell transplantation in multiple myeloma patients. |
| PubMedID- 23648347 | [retrospective analysis on therapeutic effect of autologous hematopoietic stem cell transplantation in multiple myeloma patients]. |
| PubMedID- 21509689 | Allogeneic hematopoietic stem cell transplantation in multiple myeloma has been performed since the 1980th, but is still a controversial treatment modality. |
| PubMedID- 22385049 | Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma. |
| PubMedID- 21779930 | Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery. |
| PubMedID- 22498745 | Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma. |
| PubMedID- 23872222 | A randomized phase ii trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma. |
| PubMedID- 25911579 | hematopoietic stem cell transplantation in multiple myeloma: a retrospective study of the societe francaise de greffe de moelle et de therapie cellulaire (sfgm-tc). |
| PubMedID- 25131852 | Role of hematopoietic stem cell transplantation in multiple myeloma. |
| PubMedID- 23668200 | [analysis of the efficacy and prognosis on first-line autologous hematopoietic stem cell transplantation of patients with multiple myeloma]. |
| PubMedID- 23205257 | Update on the role of autologous hematopoietic stem cell transplantation in multiple myeloma. |
| PubMedID- 25830131 | Further studies should target the identification of patients at high risk of hbv reactivation in multiple myeloma treated with autologous hematopoietic stem cell transplantation and steroid therapy for maintenance and establish viral prophylaxis strategies, especially in korea, in which hbv infection is endemic. |
| PubMedID- 22781947 | [the efficacy and safety of bortezomib-based induction regimen before autologous hematopoietic stem cell transplantation in patients with multiple myeloma]. |
| PubMedID- 23253719 | Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma. |
| PubMedID- 23690782 | The tenth paper entitled “lenalidomide before and after autologous hematopoietic stem cell transplantation in multiple myeloma” by s. a. tuchman et al. |
| PubMedID- 22690220 | Although multiple myeloma remains incurable outside of allogeneic hematopoietic stem cell transplantation, novel agents made available only in the last few decades have nonetheless tremendously improved the landscape of myeloma treatment. |
| PubMedID- 24280455 | Autologous hematopoietic stem cell transplantation for patients with multiple myeloma: an overview for nurses in community practice. |
| PubMedID- 21919958 | Non-cryopreserved hematopoietic stem cell transplantation in multiple myeloma, a single center experience. |
| PubMedID- 23436046 | The purposes of this study were to evaluate the infection by hepatitis b virus (hbv) and its impact on survival and to provide a clinical reference for monitoring and treating hbv during and after autologous hematopoietic stem cell transplantation (asct) in patients with multiple myeloma (mm). |
Page: 1